Men with prostate cancer that returns after surgery or radiation and are left with few options could benefit from a new ...

The Food and Drug Administration is announcing the first round of drugs that will receive drastically expedited reviews at ...

The U.S. Food and Drug Administration on Thursday announced the names of nine products, under a new fast-track review process ...

The U.S. Food and Drug Administration has approved Amgen and AstraZeneca's drug for a type of chronic inflammatory sinus ...

The U.S. Food and Drug Administration has approved Amgen and AstraZeneca's drug for a type of chronic sinus infection, the ...

EMD Serono will sell fertility drugs on the Trump direct-to-consumer marketplace. Trump also preview plans to encourage ...

President Trump announced a pair of efforts Thursday aimed at expanding access to in vitro fertilization (IVF) as he seeks to ...

The US Food and Drug Administration has given clearance to another blood test to help assess Alzheimer’s disease and other ...

A gene therapy from Regeneron, a pancreatic cancer medicine from Revolution Medicines and a porphyria drug from Disc Medicine ...

FDA announced the first nine recipients of priority review vouchers, which offers expedited drug review to products aligned ...

The FDA's rejections of Replimune and Capricor therapies show how instability threatens biotech innovation, CEOs say.

The Food and Drug Administration recalled nearly 85 million units through the first half of the year and managing this ...